MENU
NKTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nkarta (NKTX) Earnings Date & Reports

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies... Show more

A.I. Advisor
published Earnings

NKTX is expected to report earnings to rise 9.03% to -33 cents per share on November 05

Nkarta NKTX Stock Earnings Reports
Q3'25
Est.
$-0.34
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.05
Q3'24
Missed
by $0.02
The last earnings report on August 12 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 668.99K shares outstanding, the current market capitalization sits at 156.25M.
View a ticker or compare two or three
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NKTX showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1150 Veterans Boulevard
Phone
+1 905 407-1049
Employees
150
Web
https://www.nkartatx.com